GlassScriptPhysician profile
Bruce N Le
NPI 1558465799
$6,315.01
in general payments reported to CMS, 2019-2025
24 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,423 · 2020: $3,730 · 2021: $209 · 2022: $145 · 2023: $332 · 2024: $308 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,618.17 | 2020 | |
| Sequoia Surgical, INC. | $1,661.59 | 2019-2020 | |
| Stryker Corporation | $551.66 | 2019-2025 | Mako, Aequalis Perform, Blueprint Patient Specific Instrumentation |
| Djo, LLC | $303.50 | 2019 | |
| Pacira Therapeutics, INC. | $264.64 | 2019-2021 | |
| Smith+Nephew, INC. | $216.63 | 2019-2025 | Collagenase Santyl |
| Cornerstone Medical Associates, INC. | $128.06 | 2023-2024 | |
| Skeletal Dynamics INC | $117.60 | 2023 | Align, Implate, Ijs |
| Pfizer INC. | $70.08 | 2019-2021 | |
| Bioventus LLC | $59.46 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $55.57 | 2019-2024 | Euflexxa |
| Heraeus Medical, LLC. | $42.58 | 2022-2025 | Palacos |
| Vertex Pharmaceuticals Incorporated | $34.08 | 2025 | |
| Radius Health, INC. | $28.36 | 2025 | |
| Orthofix Medical, INC. | $26.22 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $20.77 | 2022 | |
| Sanofi-Aventis U.S. LLC | $20.56 | 2019 | |
| Davol INC. | $15.63 | 2024 | Avitene Ultrafoam |
| Janssen Pharmaceuticals, INC | $15.01 | 2019 | |
| Moximed, INC | $14.50 | 2025 | Misha Knee System, Small, Left |
| Vericel Corporation | $13.66 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.75 | 2019 | |
| Endo Pharmaceuticals INC. | $12.32 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.